Sign in

CIK 0001177648

  • Non-accelerated filer
  • Smaller reporting company

ENANTA PHARMACEUTICALS INC

Sign in to watch
Ticker
ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Entity type
Operating
EIN
043205099
Phone
+1 617-607-0800
Business address
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
  1. 4 Grant or award Chief Medical Officer acquired 7,000 shares (grant or award)
  2. 4 Grant or award Sr. VP & CSO acquired 21,000 shares (grant or award)
  3. 4 Grant or award Treasurer and CFO acquired 21,000 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 63,000 shares (grant or award)
  5. 4 Grant or award Chief Medical Officer acquired 20,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Option exercise Treasurer and CFO acquired 3,480 shares (option exercise)
  8. 4 Open-market sale Sr. VP & Chief Medical Officer sold 83,344 shares at an average $71.60 ($5,967,688)
  9. 4 Open-market sale Director sold 6,000 shares at an average $67.83 ($406,970)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Sr. VP & Chief Medical Officer sold 36,820 shares at an average $70.20 ($2,584,682)
  17. 4 Shares withheld for taxes Sr. VP, Business Dev. gave up 489 shares (to pay taxes)
  18. 4 Shares withheld for taxes Sr. VP, New Product Dev. gave up 552 shares (to pay taxes)
  19. 4 Shares withheld for taxes Sr. VP & General Counsel gave up 957 shares (to pay taxes)
  20. 4 Shares withheld for taxes Sr. VP & Chief Medical Officer gave up 954 shares (to pay taxes)

Page 8 of 24 · 475 filings